Logo

Benitec Relocates to Sydney, Receives Notice of Allowance for US Patent Application

Aug 11, 2011
Premium

Benitec said this week that it has relocated its headquarters from Melbourne to Sydney in Australia.

According to the company, its CEO Peter French is based in Sydney.

The company also announced that it has received notice from the US Patent and Trademark Office that it will receive a patent on an application, No.20030159161, from its Graham patent family, which broadly covers its core expressed RNAi technology.

The company received a notice of allowance on a related patent application last month (GSN 7/28/2011).

Filed under

Gene Silencing/Gene Editing
USPTO
RNAi
Benitec
Breaking News
The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.